Live Breaking News & Updates on Ngiotensin|Page 2

Stay updated with breaking news from Ngiotensin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

IFNγ identified as crucial for reducing pulmonary viral loads in COVID-19, new research shows

The role of type-2 interferon (IFNγ) in antiviral immunity. ....

United States , Princejoy Shutterstock , Nature Communications , Bacillus Calmette Gu , Coronavirus Disease Covid 19 , Covid 19 , Ngiotensin Converting Enzyme 2 , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome ,

High-impact clinical trial results to be presented at ASN Kidney Week 2023

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2023 November 1–November 5. ....

Brad Rovin , Michelle Rheault , Danielle Ellis , Hiddo Lambers Heerspink , Patrick Rossignol , Tadao Akizawa , Amit Garg , Dan Brennan , Katheriner Tuttle , University Of Lorraine , Showa University School Of Medicine , University Of Washington , Drug Administration , University Of Minnesota Medical School , Ohio State University , London Health Sciences Centre Research Institute , University Medical Center Groningen , Ohio State , Minnesota Medical , Focal Segmental Glomerulosclerosis , Showa University School , Placebo Controlled Phase , Bardoxolone Methyl , Diabetic Kidney Disease , Aldosterone Synthase Inhibition , Without Background Sodium Glucose Cotransporter ,

NF-κB activation during COVID-19 and its impact on patients with hypertension

Researchers review the role of NF-κB activation in the replication of SARS-CoV-2 and the impact of COVID-19 medications on NF-κB activation. ....

Hypertension Research , Coronavirus Disease Covid 19 , Monoclonal Antibody , Public Health , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome ,

In acute myocardial infarction patients, does adding a traditional Chinese medicine compound to standard treatments improve outcomes?

Researchers investigated whether Tongxinluo, a Chinese medicinal compound, could improve clinical outcomes among ST-segment elevation myocardial infarction patients. ....

Traditional Chinese Medicine Compound , Clinical Outcomes , Patients With Acute Myocardial Infarction The , Image Credit , Image Point , Myocardial Infarction , Cardiovascular Disease , Clinical Trial , N Vitro ,

Engineered bacteria could offer new treatment for hypertension

Scientists at The University of Toledo have proven that engineered bacteria can lower blood pressure, a finding that opens new doors in the pursuit of harnessing our body's own microbiome to treat hypertension. ....

Bina Joe , Lily Ramsey , Us Centers For Disease , University Of Toledo , Utoledo College Of Medicine , Pharmacological Research , Department Of Physiology , University Professor , Life Sciences , Distinguished University Professor , Disease Control , Blood Pressure ,